HKEX

The proposed launch comes as HKEX looks to boost derivatives trading and compete more aggressively with global peers.

Hong Kong bourse plans to start zero-day options in early 2027

While financial fraud remains relatively rare in Hong Kong, the city is sharpening its scrutiny of corporate quality to lure investors back following a multi-year slump in listings.

Hong Kong exchange tightens rules to avoid auditor shopping

The transactions – the majority of which occurred in the second half of 2025 – relate to prepayments in connection with new projects.

US$14.8 million in prepayments to vendors behind Mirxes’ missed 2025 results deadline; independent probe set up

Mirxes specialises in miRNA technology, developing blood-based diagnostic tests for the early detection of cancer and other diseases.

Singapore biotech Mirxes misses 2025 results deadline as auditors probe vendor payments

Hong Kong Exchanges & Clearing has said there are more than 400 companies preparing to list.

Hong Kong regulatory scrutiny puts share sale boom at risk

Hong Kong Exchanges and Clearing's net profit rose 36 per cent to HK$17.7 billion last year from HK$13.1 billion in 2024.

Hong Kong exchange posts record profit as equity turnover doubles, listings rebound

The Straits Times Index ended the year at 4,646.21, about 0.2% down.  

2025’s winners and laggards: STI posts best gains in years; South Korea, Vietnam outshine regional peers

Hong Kong dominated Asian equity capital market deals with US$75 billion raised so far this year, according to LSEG data.

Hong Kong asks investment banks to ensure IPO applications maintain standards

Hong Kong’s listings market is on track to end 2025 at a four-year high, with proceeds potentially topping US$40 billion.

Hong Kong stock rally meets HK$193.8 billion lockup test ahead